Abstract:CD8 + T cells are a crucial part of the adaptive immune system, responsible for combating intracellular pathogens and tumor cells. The initial activation of T cells involves the formation of highly dynamic Ca 2+ microdomains. Recently, purinergic signaling was shown to be involved in the formation of the initial Ca 2+ microdomains in CD4 + T cells. In this study, the role of purinergic cation channels, particularly P2X4 and P2X7, in CD8 + T cell signaling from initial events to downstream responses was investigated, focusing on various aspects of T cell activation, including Ca 2+ microdomains, global Ca 2+ responses, NFAT-1 translocation, cytokine expression, and proliferation. While Ca 2+ microdomain formation was significantly reduced in the first milliseconds to seconds in CD8 + T cells lacking P2X4 and P2X7 channels, global Ca 2+ responses over minutes were comparable between wild-type (WT) and knockout cells. However, the onset velocity was reduced in P2X4-deficient cells, and P2X4, as well as P2X7-deficient cells, exhibited a delayed response to reach a certain level of free cytosolic Ca 2+ concentration ([Ca 2+ ] i ). NFAT-1 translocation, a crucial transcription factor in T cell activation, was also impaired in CD8 + T cells lacking P2X4 and P2X7. In addition, the expression of IFN-γ, a major pro-inflammatory cytokine produced by activated CD8 + T cells, and Nur77, a negative regulator of T cell activation, was significantly reduced 18h post-stimulation in the knockout cells. In line, the proliferation of T cells after 3 days was also impaired in the absence of P2X4 and P2X7 channels. In summary, the study demonstrates that purinergic signaling through P2X4 and P2X7 enhances initial Ca 2+ events during CD8 + T cell activation and plays a crucial role in regulating downstream responses, including NFAT-1 translocation, cytokine expression, and proliferation on multiple timescales. These findings suggest that targeting purinergic signaling pathways may offer potential therapeutic interventions.

P2X7 Receptor Positively Regulates MyD88-dependent NF-κB Activation.

Lys694Arg Polymorphism Leads to Blunted Responses to LPS by Interfering TLR4 with Recruitment of MyD88

Regulation of Immune Response by P2X7 Receptor.

Inherent P2X7 Receptors Regulate Macrophage Functions during Inflammatory Diseases

The Dual Functions of IL-1 Receptor-Associated Kinase 2 in TLR9-Mediated IFN and Proinflammatory Cytokine Production

IRAK-M Mediates Toll-like Receptor/il-1R-induced NFκB Activation and Cytokine Production

P2X7 receptor activation leads to NLRP3-independent IL-1β release by human macrophages

The P2X7 receptor directly interacts with the NLRP3 inflammasome scaffold protein

The 11S Proteasome Subunit PSME3 is a Positive Feedforward Regulator of NF-κB and Important for Host Defense Against Bacterial Pathogens.

Lipopolysaccharide-induced NF-κB nuclear translocation is primarily dependent on MyD88, but TNFα expression requires TRIF and MyD88

Protein phosphatase 2A catalytic subunit α plays a MyD88-dependent, central role in the gene-specific regulation of endotoxin tolerance.

TLR agonists stimulate Nlrp3-dependent IL-1β production independently of the purinergic P2X7 receptor in dendritic cells and in vivo.

TLR3-Dependent Activation of TLR2 Endogenous Ligands Via the MyD88 Signaling Pathway Augments the Innate Immune Response

Antagonism between MyD88- and TRIF-dependent signals in B7RP-1 up-regulation.

P2X7 RECEPTOR PLAYS A CRUCIAL ROLE IN LPS‐MEDIATED ACUTE LUNG INJURY

Time-resolved role of P2X4 and P2X7 during CD8+ T cell activation

MyD88 NEDDylation Negatively Regulates MyD88-dependent NF-κB Signaling Through Antagonizing Its Ubiquitination.

Phosphatase PTP1B negatively regulates MyD88- and TRIF-dependent proinflammatory cytokine and type I interferon production in TLR-triggered macrophages.

Ctenopharyngodon Idella Tollip Regulates MyD88-induced NF-κB Activation.

The P2X7 Receptor Mediates NLRP3-dependent IL-1β Secretion and Promotes Phagocytosis in the Macrophage Response to Treponema Pallidum.

Modulation of Tlr Signaling by Multiple Myd88-Interacting Partners Including Leucine-Rich Repeat Fli-I-Interacting Proteins